|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0027530,
umls-concept:C0027651,
umls-concept:C0035020,
umls-concept:C0085862,
umls-concept:C0185117,
umls-concept:C0205216,
umls-concept:C0280324,
umls-concept:C0683956,
umls-concept:C0746922,
umls-concept:C1299583,
umls-concept:C1335797,
umls-concept:C1549571,
umls-concept:C1608386,
umls-concept:C1706163,
umls-concept:C2003905,
umls-concept:C2697524,
umls-concept:C2700445,
umls-concept:C2911684
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-4-6
|
|
pubmed:abstractText |
In primary squamous cell carcinoma of the larynx (LSCC), Ca(2+) binding S100A2 protein underexpression was already found to be associated with poor tumour differentiation and shorter overall survival. In the present work, the role of S100A2 protein expression in the prediction of regional metastasis-free survival (MFS) was investigated to guide neck management in LSCC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1916-0216
|
|
pubmed:author |
pubmed-author:AlmadoriGiovanniG,
pubmed-author:BussuFrancescoF,
pubmed-author:GalliJacopoJ,
pubmed-author:HeizmannClaus WCW,
pubmed-author:LauriolaLiberoL,
pubmed-author:MaggianoNicolaN,
pubmed-author:MichettiFabrizioF,
pubmed-author:PaludettiGaetanoG,
pubmed-author:RanellettiFranco OFO,
pubmed-author:RiganteMarioM,
pubmed-author:SchaferBeat WBW
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
38
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
16-22
|
|
pubmed:meshHeading |
pubmed-meshheading:19344608-Carcinoma, Squamous Cell,
pubmed-meshheading:19344608-Chemotactic Factors,
pubmed-meshheading:19344608-Combined Modality Therapy,
pubmed-meshheading:19344608-Follow-Up Studies,
pubmed-meshheading:19344608-Genetic Predisposition to Disease,
pubmed-meshheading:19344608-Humans,
pubmed-meshheading:19344608-Immunohistochemistry,
pubmed-meshheading:19344608-Laryngeal Neoplasms,
pubmed-meshheading:19344608-Laryngectomy,
pubmed-meshheading:19344608-Lymph Nodes,
pubmed-meshheading:19344608-Neck,
pubmed-meshheading:19344608-Neoplasm Recurrence, Local,
pubmed-meshheading:19344608-Neoplasm Staging,
pubmed-meshheading:19344608-Predictive Value of Tests,
pubmed-meshheading:19344608-Radiotherapy Dosage,
pubmed-meshheading:19344608-Recurrence,
pubmed-meshheading:19344608-S100 Proteins
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Diminished expression of S100A2, a putative tumour suppressor, is an independent predictive factor of neck node relapse in laryngeal squamous cell carcinoma.
|
|
pubmed:affiliation |
Institute of Otolaryngology, Catholic University of the Sacred Heart, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article
|
